{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:18:53Z","timestamp":1793830733241,"version":"4.6.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.mcn.2025.104070","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:00:21Z","timestamp":1767114021000},"page":"104070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Precision therapeutic strategies for Alzheimer's disease: Amyloid \u03b2\u2013targeted foundations and multimodal next-generation approaches"],"prefix":"10.1016","volume":"136","author":[{"given":"Imran","family":"Zafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sohail","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayez Saeed","family":"Bahwerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeeb Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.mcn.2025.104070_bb0005","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2174\/011570159X341703250130064735","article-title":"Informatics approach towards targeting HTR1B pathways in neuropharmacology for migraine treatment","volume":"6;23","author":"Ahmad","year":"2025","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0010","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12885-025-14113-z","article-title":"Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis","volume":"25","author":"Ahmad","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0015","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.30574\/ijsra.2023.8.1.0189","article-title":"Artificial intelligence in multi-omics data integration: advancing precision medicine, biomarker discovery and genomic-driven disease interventions","volume":"8","author":"Ali","year":"2023","journal-title":"Int. J. Sci. Res. Arch."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0020","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1038\/s41598-024-56489-1","article-title":"Predicting early Alzheimer\u2019s with blood biomarkers and clinical features","volume":"14","author":"AlMansoori","year":"2024","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.mcn.2025.104070_bb0025","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1021\/acschemneuro.1c00540","article-title":"Engineered solid lipid nanoparticles and nanostructured lipid carriers as new generations of blood\u2013brain barrier transmitters","volume":"12","author":"Amiri","year":"2021","journal-title":"ACS Chem. Nerosci."},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0030","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/ijms24043754","article-title":"Alzheimer\u2019s disease: an updated overview of its genetics","volume":"24","author":"Andrade-Guerrero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2025.104070_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117795","article-title":"Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases","volume":"242","author":"Arshad","year":"2024","journal-title":"Environ. Res."},{"issue":"5","key":"10.1016\/j.mcn.2025.104070_bb0040","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/bcp.70021","article-title":"Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer\u2019s disease: the pharmacovigilance perspective","volume":"91","author":"Bobbins","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"16","key":"10.1016\/j.mcn.2025.104070_bb0045","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.3390\/jcm13164661","article-title":"Biomarker-based precision therapy for Alzheimer\u2019s disease: multidimensional evidence leading a new breakthrough in personalized medicine","volume":"13","author":"Bougea","year":"2024","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.mcn.2025.104070_bb0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.14283\/jpad.2024.37","article-title":"Anti-amyloid therapies for Alzheimer\u2019s disease: an Alzheimer Europe position paper and call to action","volume":"11","author":"Bradshaw","year":"2024","journal-title":"J. Prev Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.mcn.2025.104070_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.mcn.2025.104070_bb0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/amajethics.2023.777","article-title":"What might aducanumab teach us about clinicians\u2019 judgment about whether to recommend emerging Alzheimer\u2019s interventions?","volume":"25","author":"Burroughs","year":"2023","journal-title":"AMA J. Ethics"},{"issue":"10","key":"10.1016\/j.mcn.2025.104070_bb0065","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mcn.2025.104070_bb0070","doi-asserted-by":"crossref","DOI":"10.7717\/peerj-cs.2784","article-title":"Early detection and analysis of accurate breast cancer for improved diagnosis using deep supervised learning for enhanced patient outcomes","volume":"11","author":"Chetry","year":"2025","journal-title":"PeerJ Comput. Sci."},{"issue":"5","key":"10.1016\/j.mcn.2025.104070_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/jama.2020.15085","article-title":"Apoe \u025b4 allele testing and risk of Alzheimer disease","volume":"325","author":"Choudhury","year":"2021","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0080","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.eururo.2015.08.033","volume":"70","author":"Cumberbatch","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mcn.2025.104070_bb0085","article-title":"Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer\u2019s disease: strategies and research directions","volume":"e00570","author":"Cummings","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.mcn.2025.104070_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40263-024-01103-1","article-title":"Alzheimer\u2019s disease: combination therapies and clinical trials for combination therapy development","volume":"38","author":"Cummings","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mcn.2025.104070_bb0095","article-title":"Drug delivery strategies to cross the blood-brain barrier in Alzheimer\u2019s disease: a comprehensive review on three promising strategies","volume":"100204","author":"de Koning","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.mcn.2025.104070_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105911","article-title":"TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors","volume":"173","author":"de Oliveira","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.mcn.2025.104070_bb0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41593-018-0145-x","article-title":"Microglial immune checkpoint mechanisms","volume":"21","author":"Deczkowska","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mcn.2025.104070_bb0110","first-page":"1","article-title":"Donanemab for Alzheimer\u2019s disease: from preclinical research to the clinical application","author":"Dodel","year":"2025","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.mcn.2025.104070_bb0115","series-title":"What are the Reasons for the Repeated failures of Clinical Trials With Anti-amyloid Drugs for AD Treatment?","first-page":"e2025E2001","volume":"vol. 19","author":"Forlenza","year":"2025"},{"key":"10.1016\/j.mcn.2025.104070_bb0120","series-title":"Do I Look at You with Love?: Reimagining the Story of Dementia","volume":"vol. 9","author":"Freeman","year":"2021"},{"key":"10.1016\/j.mcn.2025.104070_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.937133","article-title":"Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight","volume":"15","author":"Goel","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.mcn.2025.104070_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103691","article-title":"Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm","volume":"74","author":"Grabowska-Pyrzewicz","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease\u2014one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.mcn.2025.104070_bb0140","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.mcn.2025.104070_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer\u2019s disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6526","key":"10.1016\/j.mcn.2025.104070_bb0155","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.abd7331","article-title":"Learning the language of viral evolution and escape","volume":"371","author":"Hie","year":"2021","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mcn.2025.104070_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","article-title":"The unfolded protein response is activated in Alzheimer\u2019s disease","volume":"110","author":"Hoozemans","year":"2005","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.mcn.2025.104070_bb0165","first-page":"1","article-title":"Bringing greater accuracy to Europe\u2019s healthcare systems: the unexploited potential of biomarker testing in oncology","volume":"5","author":"Horgan","year":"2020","journal-title":"Biomedicine hub"},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi-target drug design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"issue":"2","key":"10.1016\/j.mcn.2025.104070_bb0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau\u2014a toxic pas de deux in Alzheimer\u2019s disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.cdd.4401528","article-title":"Amyloid \u03b2 induces neuronal cell death through ROS-mediated ASK1 activation","volume":"12","author":"Kadowaki","year":"2005","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.mcn.2025.104070_bb0195","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased A\u03b242 and decreased A\u03b240","volume":"27","author":"Kumar-Singh","year":"2006","journal-title":"Hum. Mutat."},{"issue":"9","key":"10.1016\/j.mcn.2025.104070_bb0200","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A\u03b2 accumulation in Alzheimer\u2019s disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0205","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.conb.2012.01.001","article-title":"Respiratory circuits: development, function and models","volume":"22","author":"Mellen","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.mcn.2025.104070_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1400544","article-title":"Neurotoxic \u03b2-amyloid oligomers cause mitochondrial dysfunction\u2014the trigger for PANoptosis in neurons","volume":"16","author":"Meng","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"18","key":"10.1016\/j.mcn.2025.104070_bb0215","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mcn.2025.104070_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/trc2.12456","article-title":"Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau-181 in dried plasma spots","volume":"10","author":"Mohaupt","year":"2024","journal-title":"Alzheimer's Dement. Transl. Res. Clin. Interv."},{"issue":"6","key":"10.1016\/j.mcn.2025.104070_bb0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.13931","article-title":"Economic burden of Alzheimer disease and related dementias by race and ethnicity, 2020 to 2060","volume":"8","author":"Mudrazija","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.mcn.2025.104070_bb0235","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer\u2019s disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1039\/C8MT00203G","article-title":"Cu and Zn interactions with A\u03b2 peptides: consequence of coordination on aggregation and formation of neurotoxic soluble A\u03b2 oligomers","volume":"11","author":"Rana","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.mcn.2025.104070_bb0245","series-title":"Deep Learning for Health and Medicine. Deep Learning for Personalized Healthcare Services","volume":"1","author":"Rayan","year":"2021"},{"issue":"3","key":"10.1016\/j.mcn.2025.104070_bb0250","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/alz.13532","article-title":"Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE \u03b54 homozygotes","volume":"20","author":"Riviere","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.mcn.2025.104070_bb0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0260","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/ATVBAHA.120.311911","article-title":"Vascular hypothesis of Alzheimer disease: topical review of mouse models","volume":"41","author":"Scheffer","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.mcn.2025.104070_bb0265","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/jcph.765","article-title":"Precision oncology medicine: the clinical relevance of patient-specific biomarkers used to optimize cancer treatment","volume":"56","author":"Schmidt","year":"2016","journal-title":"J. Clin. Pharmacol."},{"issue":"7698","key":"10.1016\/j.mcn.2025.104070_bb0270","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nature25978","article-title":"Planning chemical syntheses with deep neural networks and symbolic AI","volume":"555","author":"Segler","year":"2018","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.mcn.2025.104070_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mcn.2025.104070_bb0280","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.mcn.2025.104070_bb0285","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70492","article-title":"The clinical trials landscape for Alzheimer\u2019s disease","volume":"31","author":"Shen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"10","key":"10.1016\/j.mcn.2025.104070_bb0290","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.bbadis.2014.04.004","article-title":"Cerebellar ataxia and functional genomics: identifying the routes to cerebellar neurodegeneration","volume":"1842","author":"Smeets","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.mcn.2025.104070_bb0295","article-title":"Anti-amyloid trials raise scientific and ethical questions","volume":"372","author":"Smith","year":"2021","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0300","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0305","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0310","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13041-016-0284-5","article-title":"The neurotoxicity of amyloid \u03b2-protein oligomers is reversible in a primary neuron model","volume":"10","author":"Tanokashira","year":"2017","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0315","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-024-00745-5","article-title":"Therapeutic potential of APP antisense oligonucleotides for Alzheimer\u2019s disease and down syndrome-related Alzheimer\u2019s disease","volume":"19","author":"Thirumalai","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.mcn.2025.104070_bb0320","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1139\/gen-2020-0104","article-title":"Transcriptional enhancers: from prediction to functional assessment on a genome-wide scale","volume":"64","author":"Tobias","year":"2021","journal-title":"Genome"},{"issue":"11","key":"10.1016\/j.mcn.2025.104070_bb0325","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3390\/jcm13113098","article-title":"Novel therapeutic strategies in Alzheimer\u2019s disease: pitfalls and challenges of anti-amyloid therapies and beyond","volume":"13","author":"Tondo","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0330","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer\u2019s disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.mcn.2025.104070_bb0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","article-title":"P-selectin-targeted nanocarriers induce active crossing of the blood\u2013brain barrier via caveolin-1-dependent transcytosis","volume":"22","author":"Tylawsky","year":"2023","journal-title":"Nat. Mater."},{"issue":"6","key":"10.1016\/j.mcn.2025.104070_bb0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcn.2025.104070_bb0350","first-page":"1","article-title":"Challenges in the clinical application of machine learning for pancreatic cancer","author":"Ve\u010durkovsk\u00e1","year":"2025","journal-title":"Bratislava Med. J."},{"issue":"7","key":"10.1016\/j.mcn.2025.104070_bb0355","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/acn3.52042","article-title":"Amyloid-related imaging abnormalities (ARIA): diagnosis, management, and care in the setting of amyloid-modifying therapy","volume":"11","author":"Vukmir","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.mcn.2025.104070_bb0360","first-page":"1","article-title":"Blood\u2013brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"issue":"s1","key":"10.1016\/j.mcn.2025.104070_bb0365","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.3233\/JAD-231258","article-title":"BACE inhibitor clinical trials for Alzheimer\u2019s disease","volume":"101","author":"Watkins","year":"2024","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.mcn.2025.104070_bb0370","series-title":"Irisin as a Mediator of the Positive Relationship between Exercise and the Brain in Health and Alzheimer\u2019s Disease","author":"White","year":"2025"},{"key":"10.1016\/j.mcn.2025.104070_bb0375","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/hast.4992","article-title":"The quest for cure of \u201cAlzheimer\u2019s\u201d: reimagining the goal by changing culture","volume":"55","author":"Whitehouse","year":"2025","journal-title":"Hastings Cent. Rep."},{"key":"10.1016\/j.mcn.2025.104070_bb0380","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrn2860","article-title":"The symphony of transcription","volume":"11","author":"Wiedemann","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.mcn.2025.104070_bb0385","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.mcn.2025.104070_bb0390","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/aps.2017.105","article-title":"The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation","volume":"38","author":"Wu","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.mcn.2025.104070_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvman.2025.125787","article-title":"Degradation of typical tetracycline antibiotics in landfill leachate by three-dimensional aerated electrocatalytic reactor (3D-AER): electrode properties, influencing factors and degradation mechanism","volume":"386","author":"Xie","year":"2025","journal-title":"J. Environ. Manage."},{"issue":"2","key":"10.1016\/j.mcn.2025.104070_bb0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn3407","article-title":"Animal models of traumatic brain injury","volume":"14","author":"Xiong","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"26","key":"10.1016\/j.mcn.2025.104070_bb0405","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1073\/pnas.0711664105","article-title":"Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly","volume":"105","author":"Xue","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0410","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.mcn.2025.104070_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104665","article-title":"Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"94","author":"Yu","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mcn.2025.104070_bb0420","article-title":"Molecular biology in the exabyte era: taming the data deluge for biological revelation and clinical transformation","volume":"108535","author":"Zafar","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.mcn.2025.104070_bb0425","first-page":"85","article-title":"Advances in blood biomarkers for Alzheimer\u2019s disease: ultra-sensitive detection technologies and impact on clinical diagnosis","author":"Zhang","year":"2024","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"1","key":"10.1016\/j.mcn.2025.104070_bb0430","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","article-title":"Pathological mechanisms and treatment progression of Alzheimer\u2019s disease","volume":"30","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"9","key":"10.1016\/j.mcn.2025.104070_bb0435","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.mcn.2025.104070_bb0440","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743125000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743125000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:50:50Z","timestamp":1773831050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743125000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":87,"alternative-id":["S1044743125000806"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2025.104070","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision therapeutic strategies for Alzheimer's disease: Amyloid \u03b2\u2013targeted foundations and multimodal next-generation approaches","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2025.104070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104070"}}